Bluelight Mobile DigiPharm presentation Sam Walmsley
Mobile presentation from Bluelight Digipharm pre-workshop. Covering why pharma should be thinking about creating seamless digital experiences that work across all devices. Healthcare and patient stats on mobile usage. Thoughts on whether to create mobile content or develop apps.
Bluelight Mobile DigiPharm presentation Sam Walmsley
Mobile presentation from Bluelight Digipharm pre-workshop. Covering why pharma should be thinking about creating seamless digital experiences that work across all devices. Healthcare and patient stats on mobile usage. Thoughts on whether to create mobile content or develop apps.
Regulation of health apps -A practical guide january 2012Sam Walmsley
Regulation of health apps: A practical guide from Bluelight www.bluelightpartners.com and D4 www.d4.org.uk
The primary purpose of this guide is to highlight the challenges that surround the provision and use of health apps from a regulatory standpoint, whether as a patient, health care professional, application developer, healthcare organisation, pharmaceutical or medical devices company.
There are three key questions we wanted to address in this guide:
How are health apps regulated, and how do I know if they are safe to use?
What other issues should I consider if I’m developing a health app?
How can I support the use of health apps across my organization?
Mobile marketing for healthcare and pharmaceutical- EyeForPharma presentation...Sam Walmsley
EyeForPharma presentation on Mobile Marketing for healthcare and pharmaceutical companies. Covering the need for web friendly content, mobile marketing tactics including SEO for mobile, PPC, Advertising, SMS/MMS, discussion on augmented reality (AR) and NFC
Meten van functioneren in de dagelijkse praktijk: Wat kunnen we leren van het...Ontogenese
Deze presentatie heb ik verzorgd op de NVR Najaarsdagen 2018. Het nationale reumatologie congres in Nederland. Ik werd gevraagd te presenteren over de optimale manier om functioneren te meten in de dagelijkse (fysiotherapie)praktijk. In mijn onderzoekslijn op IQ healthcare, werk ik samen met de University of Colorado, aan de ontwikkeling van persoonsgerichte herstelcurves. Het is mijn ambitie om deze groeicurves uiteindelijk in de dagelijkse praktijk te implementeren.
Regulation of health apps -A practical guide january 2012Sam Walmsley
Regulation of health apps: A practical guide from Bluelight www.bluelightpartners.com and D4 www.d4.org.uk
The primary purpose of this guide is to highlight the challenges that surround the provision and use of health apps from a regulatory standpoint, whether as a patient, health care professional, application developer, healthcare organisation, pharmaceutical or medical devices company.
There are three key questions we wanted to address in this guide:
How are health apps regulated, and how do I know if they are safe to use?
What other issues should I consider if I’m developing a health app?
How can I support the use of health apps across my organization?
Mobile marketing for healthcare and pharmaceutical- EyeForPharma presentation...Sam Walmsley
EyeForPharma presentation on Mobile Marketing for healthcare and pharmaceutical companies. Covering the need for web friendly content, mobile marketing tactics including SEO for mobile, PPC, Advertising, SMS/MMS, discussion on augmented reality (AR) and NFC
Meten van functioneren in de dagelijkse praktijk: Wat kunnen we leren van het...Ontogenese
Deze presentatie heb ik verzorgd op de NVR Najaarsdagen 2018. Het nationale reumatologie congres in Nederland. Ik werd gevraagd te presenteren over de optimale manier om functioneren te meten in de dagelijkse (fysiotherapie)praktijk. In mijn onderzoekslijn op IQ healthcare, werk ik samen met de University of Colorado, aan de ontwikkeling van persoonsgerichte herstelcurves. Het is mijn ambitie om deze groeicurves uiteindelijk in de dagelijkse praktijk te implementeren.